Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development

Meenakshi Srinivasan, Annesha White (), Ayyappa Chaturvedula, Valvanera Vozmediano, Stephan Schmidt, Leo Plouffe and La’Marcus T. Wingate
Additional contact information
Meenakshi Srinivasan: University of North Texas System College of Pharmacy
Annesha White: University of North Texas System College of Pharmacy
Ayyappa Chaturvedula: University of North Texas System College of Pharmacy
Valvanera Vozmediano: University of Florida
Stephan Schmidt: University of Florida
Leo Plouffe: Bayer HealthCare
La’Marcus T. Wingate: Howard University

PharmacoEconomics, 2020, vol. 38, issue 10, No 2, 1042 pages

Abstract: Abstract Pharmacometrics is the science of quantifying the relationship between the pharmacokinetics and pharmacodynamics of drugs in combination with disease models and trial information to aid in drug development and dosing optimization for clinical practice. Considering the variability in the dose–concentration–effect relationship of drugs, an opportunity exists in linking pharmacokinetic and pharmacodynamic model-based estimates with pharmacoeconomic models. This link may provide early estimates of the cost effectiveness of drug therapies, thus informing late-stage drug development, pricing, and reimbursement decisions. Published case studies have demonstrated how integrated pharmacokinetic–pharmacodynamic–pharmacoeconomic models can complement traditional pharmacoeconomic analyses by identifying the impact of specific patient sub-groups, dose, dosing schedules, and adherence on the cost effectiveness of drugs, thus providing a mechanistic basis to predict the economic value of new drugs. Greater collaboration between the pharmacoeconomics and pharmacometrics community can enable methodological improvements in pharmacokinetic–pharmacodynamic–pharmacoeconomic models to support drug development.

Date: 2020
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40273-020-00944-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00944-0

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-020-00944-0

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().